Drugs A-Z Is my price fair? Price changes Drug markups Drug shortages Recalls Medicare prices Upcoming generics What people paid Guides Share what you paid
Theme
Class IITerminatedD-1327-2020

Drug recall · July 1, 2020

Sterile Curcumin recall

Why: Lack of Assurance of Sterility and Marketed without an approved NDA/ANDA: Product contains unapproved Cannabidiol and Curcumin

Class II: could cause temporary or reversible health problems; serious harm is remote.

The recall

Product

Sterile Curcumin, 4mg/mL, 10mL vial

Lots / codes

Lot #: 2H071219CCD, 2H0712019CCD, 2H07122019CCD, Exp. Date 7/12/2021

Quantity
N/A
Company
BIOTA Biosciences LLC, Seattle, WA
Distribution
Nationwide within the United States and New Zealand
Initiated
May 11, 2020 · Voluntary: Firm initiated
Classified
June 19, 2020
Reported
July 1, 2020
Ended
December 3, 2020
How notified
E-Mail

If you have this product

  1. Check the lot number on your package against the lots above. Only those lots are recalled.
  2. Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
  3. Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
  4. Return or dispose of recalled product as the company or your pharmacy advises.

Recalled with it (same recall event)

Questions about this recall

Be kind and stay on topic. No personal health details, links or selling. This is not medical advice.

No comments yet. Questions, tips, what worked for you - start the conversation.

Help the next person

Know what your pharmacy pays.

Every price you share shows someone else what's fair - and which pharmacies charge the least. It takes 30 seconds and it's anonymous.